US Stock MarketDetailed Quotes

EGRX Eagle Pharmaceuticals

Watchlist
  • 5.720
  • -0.020-0.35%
Close Jul 26 16:00 ET
74.12MMarket Cap6.50P/E (TTM)

Eagle Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Eagle Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2023 Earnings

Aug 8, 2023

Revenue(YoY)

64.65M

-12.80%
EPS(YoY)

0.39

+152.70%
Analyst Rating

No Data

Eagle Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 8, 20232023/Q264.646M / 59.365M--
May 9, 20232023/Q166.305M / 63.287M--
Mar 13, 20232022/Q460.699M / 64.259M--
Nov 7, 20222022/Q365.901M / 62.077M--
Aug 9, 20222022/Q274.136M / 116.886M--
DatePeriodRevenue/EstimateEarnings Call
Aug 8, 20232023/Q264.646M / 59.365M--
May 9, 20232023/Q166.305M / 63.287M--
Mar 13, 20232022/Q460.699M / 64.259M--
Nov 7, 20222022/Q365.901M / 62.077M--
Aug 9, 20222022/Q274.136M / 116.886M--

Unlock Free Earnings Estimates

Eagle Pharmaceuticals Earnings Reports

  • Eagle Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Aug 9, 2023 16:17 ET

  • Eagle Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:10 ET

  • Eagle Pharmaceuticals | 10-Q: Q1 2023 Earnings Report

    May 9, 2023 16:43 ET

  • Eagle Pharmaceuticals | 10-K: FY2022 Annual Report

    Mar 23, 2023 16:55 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg